Astellas Pharma Inc. ( ALPMY) - Stock Earnings
ALPMY Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 29, 2026, midnight | — / — | — | — / — | — |
ALPMY Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | 475.8 million USD | 3.5 billion USD |
| 2025Q3 | 544.6 million USD | 3.6 billion USD |
| 2025Q4 | 652.0 million USD | 3.7 billion USD |
| 2026Q3 Est. | — | — |
ALPMY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 743.2 million USD | 11.4 billion USD |
| 2024 | 112.6 million USD | 10.6 billion USD |
| 2025 | 339.8 million USD | 12.8 billion USD |
| 2026 Est. | — | — |
ALPMY
Price: $13.60
Dividend Yield: 3.45%
Forward Dividend Yield: 6.22%
Dividend Per Share: 0.83 USD
Earnings Per Share: 1.02 USD
P/E Ratio: 13.70
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 23.8 billion
Average Dividend Frequency: 3
Years Paying Dividends: 18
DGR3: 7.50%
DGR5: 9.03%
DGR10: 6.35%